Former JD(S) President AH Vishwanath announces retirement from politics

Mangaluru, May 6: A day after a wild bison dies lost its life hours after being tranquilized in Mangaluru, another wild bison appeared in the Ashok Nagar area of the coastal city today.

In fact, two bison were spotted in Mangaluru yesterday. The two were reportedly wandering together early in the morning. Later one was spotted in Mannagudda and the other in Hathill area.

While one of them was tranquillized by an official of a Pilikula Biological Park and captured, another bison had gone missing.

The captured animal, however, died later in the day due to cardiac arrest.

According to official, it is common for herbivores, which are sedated to ensure their safe capture, to suffer cardiac arrest.

Meanwhile, Forest department officials have launched an operation to capture the second bison. It is believed that it is the same bison which went missing yesterday.

Also Read: Wild bison intrudes into Mangaluru city amidst lockdown; captured

Mangaluru, May 6: Amidst delay in repatriation of Kannadigas stuck in Gulf countries including UAE and Saudi Arabia, on behalf of the office bearers, the executive committee and members of the Bearys Chamber of Commerce & Industry, its president Mr S M Rasheed Haji and executive committee member U T Ifthikar Ali today (May 6) called on authorities concerned in Dakshina Kannada to persuade them to follow up with the State and Central level authorities.  

The duo met Nalin Kumar Kateel, Dakshina Kannada MP, who immediately contacted Pralhad Joshi, Minister of Parliamentary Affairs, over phone and urged him to take up the issue with the external affairs ministry. Mr Joshi told Mr Kateel that efforts are still underway to bring back Kannadigas stranded in Gulf countries. However flights schedules are yet to be finalised.

The duo then met Kota Srinivas Poojary, district in-charge minister, who said that the government is prepared to handle the repatriation flights and passengers. 

The duo also met IAS officer Rahul Shinde, who is in-charge of affairs related to international passengers coming to Dakshina Kannada amid covid-19 crisis. Meanwhile, Zakariya Jokatte, president of Jubail unit of BCCI, spoke to Mr Shindhe over phone.

The official explained that the govt has made elaborate arrangements to conduct medical test of passengers on arrival at the Mangaluru International Airport. 

The passengers will be categorised into A, B and C groups depending on their symptoms and co-morbid conditions. The category A passengers (symptomatic passengers) will be sent to isolation hospitals which may be Covid care centres. Category B passengers (asymptomatic but suffering from co-morbid conditions) will be quarantined at hotels, hostels, guest houses etc. Category C passengers (asymptomatic and healthy) will be home quarantined.

The minister and official also sought BCCI’s cooperation in handling the situation. 

Quarantine accommodation facility 

Yenepoya group has already offered two of their hotels as quarantine accommodation and promised to offer one more.  Entrepreneur U Kanachur Monu and many others too have offered their hotels as quarantine accommodation in Mangaluru. 

District administration has asked Treebo, a hotel aggregator to list such willing facilities on their website.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.